Abbasi, S. (2024) “A pilot study of activity of pembrolizumab and low dose chemotherapy in relapsed/refractory T-cell lymphoma: Jordanian experience”, Acta Biomedica Atenei Parmensis, 95(5), p. e2024102. doi:10.23750/abm.v95i5.15559.